Tokyo, Japan – 19 September 2017: Sosei Group Corporation (‘Sosei’; TSE Mothers Index 4565), an international biopharmaceutical company originating from Japan, today announces the appointment of Chris Cargill as Head of Investor Relations and Corporate Communications and Kieran Johnson as the company’s Group Financial Controller.
Mr. Cargill joins Sosei from J.P. Morgan, where he was a Vice President in the U.K. Healthcare Investment Banking and Corporate Broking Group and focused on the life sciences industry, including the pharmaceutical and biotechnology sectors. Mr. Cargill brings a wealth of experience across corporate broking, investor relations, capital markets, and strategic advisory. He began his career in the Corporate Finance M&A division of KPMG, and holds double bachelor’s degrees in law and business (banking & finance), and a Diploma in Languages (Japanese) from Monash University in Melbourne, Australia. Mr. Cargill is employed by Heptares Therapeutics Limited, a wholly-owned subsidiary of Sosei.
Mr. Johnson was most recently Financial Controller for GlaxoSmithKline’s UK pharmaceuticals sales and marketing division. Over the course of his 25-plus year career, he has gained diverse international experience in financial reporting, financial compliance and M&A, and in addition worked on the creation of ViiV Healthcare, GSK’s HIV joint venture with Pfizer. Mr. Johnson commenced his accounting career at KPMG, where he spent 10 years on diversified financial and due diligence assignments specializing in pharmaceutical companies. He is a Fellow of the Institute of Chartered Accountants in England and Wales and holds a Bachelor of Science (Hons) from the University of Bath in the U.K.
Commenting on the appointments, Peter Bains, CEO at Sosei, said: “I am delighted to welcome Chris and Kieran to the team as we continue to build Sosei into a global biopharmaceutical presence. Chris’ industry perspectives and experience will be crucial as we move forward with our strategic business initiatives and build our international profile. Similarly, Kieran’s global financial controls experience will enable him to play a key role leading initiatives that support our growth ambitions. I look forward to working with both Chris and Kieran in their new roles.”